Your browser doesn't support javascript.
loading
An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease.
Srivastava, Shashikant; Pasipanodya, Jotam G; Heysell, Scott K; Boorgula, Gunavanthi D; Gumbo, Tawanda; McShane, Pamela J; Philley, Julie V.
Afiliação
  • Srivastava S; Department of Pulmonary Immunology, University of Texas at Tyler, Tyler, Texas, USA; Department of Immunology, UT Southwestern Medical Center, Dallas, Texas, USA; Department of Pharmacy Practice, Texas Tech University Health Science Center, Dallas, Texas, USA. Electronic address: Shashi.kant@uthct.e
  • Pasipanodya JG; Quantitative Preclinical & Clinical Sciences Department, Praedicare Inc., Dallas, Texas, USA.
  • Heysell SK; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
  • Boorgula GD; Department of Pulmonary Immunology, University of Texas at Tyler, Tyler, Texas, USA.
  • Gumbo T; Quantitative Preclinical & Clinical Sciences Department, Praedicare Inc., Dallas, Texas, USA.
  • McShane PJ; Section of Pulmonary and Critical Care, University of Texas at Tyler, Tyler, Texas, USA.
  • Philley JV; Section of Pulmonary and Critical Care, University of Texas at Tyler, Tyler, Texas, USA.
J Glob Antimicrob Resist ; 28: 71-77, 2022 03.
Article em En | MEDLINE | ID: mdl-34933140
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium kansasii / Pneumopatias Limite: Humans Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium kansasii / Pneumopatias Limite: Humans Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article